Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction-Reference-Cited by-同舟云学术

Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction

Published:2012-01-18 Issue:1 Volume:34 Page:65-72
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Candemir Basar,Kilickap Mustafa,Ozcan Ozgur Ulas,Kaya Cansin Tulunay,Gerede Menekse,Ozdemir Aydan Ongun,Ozdol Cagdas,Kumbasar Deniz,Erol Cetin

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-012-0685-y.pdf

Reference46 articles.

1. Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 361:13–20

2. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B et al (2011) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation 124(23):574–651

3. Simes RJ, Topol EJ, Holmes DR Jr, White HD, Rutsch WR, Vahanian A et al (1995) Link between the angiographic sub study and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I investigators. Circulation 91:1923–1928

4. Stenestrand U, Lindback J, Wallentin L (2006) Long-term outcome of primary percutaneous coronary intervention vs. prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 296:1749–1756

5. Schomig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M et al (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084–1089

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of catheter‐based drug delivery in a hybrid in vitro model of cardiac microvascular obstruction with porcine microthrombi;Bioengineering & Translational Medicine;2023-12-08

2. Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials;Heliyon;2023-05

3. Enhanced Drug Delivery for Cardiac Microvascular Obstruction with an Occlusion-Infusion-Catheter;Annals of Biomedical Engineering;2023-01-21

4. Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial;Frontiers in Cardiovascular Medicine;2021-08-02

5. Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study;The International Journal of Cardiovascular Imaging;2020-02-20